Recent studies have shown that MSI‐type colorectal tumors exhibit a relatively low frequency of BRAF and KARS mutations (Febbo et al., 2011; Funkhouser et al., 2012; Ogino, Kawasaki, Kirkner, Loda, & Fuchs, 2006). This evidence concerns the gene KARS1 and colorectal neoplasm.